IFF stock trades in the low $80s as Q2 2026 miss and guidance cut reshape expectations
Published on 08/18/2026 at 15:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
IFF Inc. (ISIN US4595061015) stock is trading in the low $80s in mid-August 2026 as investors digest a weaker-than-expected Q2 2026 earnings print and a reset of the company’s full-year revenue guidance for 2026, reinforcing the view that the turnaround remains a multi-quarter process as of August 18, 2026.
Q2 2026 results show revenue and EPS miss against consensus
Per a consolidated Q2 2026 overview for the period ended June 30, 2026, IFF generated quarterly revenue of $1.95 billion, a level that stands clearly below a consensus revenue figure of $2.69 billion for the same period and underscores the gap between the company’s current sales run-rate and prior market expectations. The same Q2 2026 snapshot reports earnings per share of $0.20 versus a consensus EPS figure of $1.12, highlighting a shortfall of $0.92 per share and signaling that restructuring, portfolio optimization, and cost programs are still weighing on near-term profitability.
In that Q2 2026 context, adjusted profit and top-line growth were described as improving versus the prior year, but the magnitude of the miss versus consensus is what stands out numerically, with the $1.95 billion reported revenue trailing the $2.69 billion expectation by $0.74 billion and the $0.20 EPS result falling short of the $1.12 consensus by more than four-fifths. For investors, these deltas quantify why the stock has not re-rated more aggressively despite operational progress, and they frame the need for further efficiency and margin work across IFF’s core franchises.
The Q2 2026 period ended June 30, 2026, is the most recent completed quarter available by mid-August 2026, so its figures form the current fundamental base case. With a reported EBITDA figure that market data places at $1.88 billion on a trailing basis and an EV/EBITDA multiple of 14.55, the valuation lens suggests that the shares are priced for a moderate recovery in earnings rather than a full normalization, consistent with the sizable gap between actual and consensus Q2 2026 numbers.
2026 guidance cut brings annual revenue outlook down to $7.4–$7.6 billion
Alongside the Q2 2026 release, IFF reset its annual guidance and now anticipates full-year 2026 revenue in a range between $7.4 billion and $7.6 billion, down from much higher expectations that had previously been embedded in consensus models and that were reported at $10.4 billion in one overview for the year. The reduction of the 2026 top-line outlook by nearly $3.0 billion versus that prior $10.4 billion reference point illustrates the extent to which the company is recalibrating its portfolio and taking a more cautious stance on demand conditions in flavors, fragrances, and related specialty ingredients.
This guidance band of $7.4–$7.6 billion for 2026, communicated in early August 2026, now serves as the primary anchor for investors assessing the revenue trajectory over the remainder of the year. On a simple comparison, even the top end of the new range at $7.6 billion sits $2.8 billion below the earlier $10.4 billion expectation, a shift that translates into a more measured growth profile and emphasizes execution on margins, cash generation, and debt reduction rather than aggressive top-line expansion.
The revised guidance also interacts with the Q2 2026 miss in a way that clarifies the company’s near-term priorities. With EPS for the quarter at $0.20 against a consensus of $1.12 and annual revenue now framed at $7.4–$7.6 billion instead of $10.4 billion, the combination points to a strategy of disciplined restructuring, selective investment, and portfolio streamlining rather than chasing volumes at the expense of profitability. For shareholders, the key questions over the coming quarters will be whether that more conservative top-line stance can translate into steadily higher margins and a narrowing of the gap versus consensus EPS expectations.
Shares hover in the low $80s after August 14, 2026 close
From a market-data perspective, an August 14, 2026 US trading snapshot places IFF stock at $84.18 at the close of regular hours on the New York Stock Exchange, with related data showing a level of $84.20 in associated sector graphics, indicating a broadly stable trading band in the mid-$80s as investors process the Q2 2026 reset. A separate quote page lists a last-traded price of $81.88 as of August 17, 2026 at 3:58 p.m. Eastern, representing a decline of 2.30 points, or 2.73 percent, from the prior session’s reference and signaling that the shares eased back toward the low $80s in the latest completed trading day.
Another real-time quote overview for August 17, 2026 shows IFF stock at $81.89, down 2.29 points or 2.72 percent in that session, with the level recorded as of 4:00 p.m. Eastern and confirming the same magnitude of move as the $81.88 figure cited in related data. Taken together, these numbers suggest that the shares are oscillating in a narrow corridor around the $82 mark in mid-August 2026, modestly below the $84.18 close recorded on August 14, 2026 but still well above the 52-week low reported at $51.72 in one multi-asset snapshot, highlighting a substantial recovery from the lows even as near-term volatility persists.
Market data for the broader trading profile shows IFF’s 52-week range stretching from that $51.72 low to a recent high of $79.82 in one euro-denominated feed, with the latest intraday reading at €79.82 for the European-traded line on the same date. In that context, the US-listed shares at $81.88 on August 17, 2026 sit slightly above the top of the €79.82 range referenced for the euro line, pointing to a coordinated recovery across listings and underscoring that the stock has advanced more than 50 percent from the 52-week trough while still trading below the levels implied by pre-reset revenue expectations.
Valuation, margins, and consensus context
Beyond the headline Q2 2026 miss and guidance cut, the underlying margin and valuation metrics help frame the risk-reward balance at current prices. A recent multi-factor overview reports a gross margin of 36.3 percent and a return on equity of 6.1 percent, figures that, while positive, reflect only moderate profitability for a company with a portfolio of high value-added fragrance and flavor ingredients. With a price-to-book ratio of 1.52 and an EV/EBITDA multiple of 14.55 on a trailing basis, the shares are positioned at a valuation that expects incremental improvement but does not yet fully price in a strong recovery in returns.
From a consensus standpoint, the miss versus Q2 2026 expectations is especially notable on EPS, where the $0.20 actual figure contrasts with the $1.12 consensus estimate and thus falls short by $0.92 per share. On revenue, the difference between the reported $1.95 billion and the $2.69 billion consensus corresponds to a shortfall of 27.5 percent, indicating that demand trends and portfolio mix have not yet converged with earlier market forecasts. These quantified gaps give investors a concrete sense of how far the company still has to go in aligning its operational performance with consensus assumptions.
At the same time, the presence of a trailing EBITDA of $1.88 billion and a relatively contained beta of 0.94 suggests that IFF retains a meaningful earnings base and does not exhibit extreme volatility versus the broader market. The combination of moderate margins, a substantial revenue scale, and a beta below 1 positions the stock as a potential candidate for investors who are willing to accept near-term execution risk in exchange for a possible multi-year normalization of returns as restructuring and portfolio changes take hold.
Flavors and fragrances portfolio remains central to the story
IFF’s core business centers on flavors, fragrances, and specialty ingredients that are embedded in consumer products ranging from packaged foods and beverages to personal care, household, and fine fragrance applications. A representative offering is its suite of flavor solutions for global food and drink brands, where the company applies proprietary sensory science, ingredient formulation, and application expertise to help customers deliver consistent taste profiles across geographies and product formats.
Within fragrances, IFF designs complex scent compositions that serve both as signature notes for branded products and as functional fragrance solutions for categories such as detergents and cleaners, where performance, stability, and consumer preference need to be balanced. The company’s capabilities in naturals, biotechnology, and sustainable sourcing also play a growing role, as consumer goods makers look for ingredients that support environmental and social responsibility goals without compromising on sensory appeal.
In specialty ingredients, IFF provides a range of materials that can include texturants, emulsifiers, and other components that enable specific functional properties in finished products, such as mouthfeel, shelf-life, or performance under varying temperature and storage conditions. Together, these segments make IFF an integral partner to branded consumer companies that rely on distinctive taste and scent to differentiate their offerings, and they underpin the revenue base that the company is targeting with its revised $7.4–$7.6 billion full-year 2026 guidance.
IFF stock stabilizes in the low $80s in mid-August 2026
As of the most recent completed US trading session cited in mid-August 2026, IFF stock closed at $81.88 on August 17, 2026 at 3:58 p.m. Eastern on the New York Stock Exchange, reflecting a one-day decline of 2.73 percent but leaving the shares still materially above the 52-week low of $51.72 reported in a multi-venue snapshot. With a market capitalization of $21.48 billion referenced for August 14, 2026 and a 52-week high point identified at €79.82 for a European-traded line, the current price level situates the stock in the upper half of its annual trading range while leaving room for further upside if the company can close the gap between actual results and consensus expectations.
For US retail investors, the key numerical anchors right now are the $1.95 billion Q2 2026 revenue versus the $2.69 billion consensus, the $0.20 EPS versus the $1.12 estimate, and the full-year 2026 revenue guidance of $7.4–$7.6 billion in place of the earlier $10.4 billion expectation. Combined with a latest US closing price of $81.88 and a 52-week low of $51.72, these figures offer a compact, quantified summary of both the fundamental and market dimensions of the IFF story in mid-August 2026.
Read more
Marketscreener Q2 2026 coverage Marketbeat IFF quote overview Tradingkey IFF price snapshot
Flavor solutions anchor the product offering
One illustrative pillar of IFF’s business is its portfolio of flavor solutions for food and beverage manufacturers, where the company blends natural extracts, synthetic ingredients, and proprietary formulations to deliver consistent taste experiences across categories such as soft drinks, dairy, confectionery, and savory snacks. These flavor systems are developed in close collaboration with customers, taking into account regional preferences, regulatory requirements, and product positioning, and they often draw on IFF’s expertise in sensory science to fine-tune sweetness, acidity, and aroma.
By supplying these integrated flavor solutions, IFF helps brand owners accelerate product development cycles, manage reformulations linked to sugar or salt reduction, and maintain consumer loyalty in crowded categories. The resilience of demand for food and beverage flavors, even in periods of macroeconomic uncertainty, is one reason why investors continue to watch the performance of this segment as a key indicator of the company’s ability to support its revised 2026 revenue guidance and improve margins over time.
Stock context for US investors
IFF stock is listed on the New York Stock Exchange under the ticker IFF, with trading denominated in US dollars and daily liquidity supported by its role as a major player in the global flavors and fragrances industry. As of August 17, 2026 at 3:58 p.m. Eastern, the latest referenced US closing price of $81.88 provides a concrete benchmark for valuation discussions, while the 52-week low of $51.72 and a recent high level around €79.82 for a European-traded line offer a sense of the range in which the shares have moved over the past year.
At that $81.88 price point and a market capitalization of $21.48 billion as of August 14, 2026, the stock reflects the market’s current assessment of IFF’s balance between execution risk and long-term potential in flavors, fragrances, and specialty ingredients. For investors evaluating the name, the quantified gaps in Q2 2026 versus consensus, the lowered 2026 revenue guidance, and the recovery from the 52-week low together form the numeric backbone of the ongoing debate over how much of the turnaround has already been priced into IFF stock.
Fact box
Company: IFF Inc.
ISIN: US4595061015
Ticker: IFF
Exchange: NYSE
Price (as of August 17, 2026, 3:58 p.m. ET): $81.88 USD
Market cap: $21.48 billion (as of August 14, 2026)
Sector / Industry: Consumer staples / Flavors and fragrances
Index membership: S&P 500
